Medically Reviewed
Key Takeaways
- The FDA approved Foundayo on April 1, 2026, for chronic weight management in eligible adults with obesity or overweight plus at least one weight-related health condition.
- Foundayo is a small-molecule GLP-1 medication designed to be taken as a pill instead of an injection.
- Foundayo can be taken once daily, with or without food, but the pill should not be crushed, broken, or chewed.
- Common Foundayo side effects may include nausea, constipation, diarrhea, vomiting, indigestion, bloating, gas, and stomach pain.
- Foundayo may affect how the body absorbs some oral medications, so current prescriptions and birth control should be discussed with a healthcare provider.
GLP-1s are expanding. Originally developed for the management of diabetes and certain cardiovascular conditions, this class of drugs has seen widespread expansion in recent years.
Foundayo, a once-daily weight loss pill, isn’t the first oral GLP-1. But it’s garnered media attention over the last few months for one big reason—convenience.
This article contains everything you need to know about Foundayo; what it is, how it works, what it’s approved for, and questions to ask your doctor if you’re thinking about making a switch.
What Is Foundayo?
Foundayo is a prescription oral GLP-1 medication from Eli Lilly. It was developed as a once-daily pill for chronic weight management in eligible adults, offering a different option from injectable GLP-1 medications such as Mounjaro and Zepbound.
Foundayo is a GLP-1 medication. Like most other GLP-1s, research shows that Foundayo can help create substantial weight loss alongside lifestyle changes. However, Foundayo stands apart from other oral GLP-1s.
- Most GLP-1s are made of peptides, or chains of amino acids. Peptide-based drugs are often required to be administered as an injection to avoid breakdown by stomach acid.
- Foundayo is a “small-molecule” GLP-1. Broadly speaking, it’s not as vulnerable to digestive processes, allowing users to take it orally.
It’s worth noting that Foundayo is not the first oral GLP-1. The Wegovy pill, for instance, uses a much larger dose because only a small fraction of oral semaglutide is absorbed into the bloodstream. Foundayo works differently as a nonpeptide, small-molecule GLP-1 medication designed for oral use without the same food or water restrictions.
Foundayo is exciting because it removes a major barrier for patients who are hesitant about injections, but convenience should never be confused with simplicity. It’s still a powerful metabolic medication, and patients need to understand the dosing, side effects, medication interactions, and warning signs before starting.
–
Dr. Sajad Zalzala, Board-certified Family Medicine Physician and Medical Advisor at SkinnyRx
What the FDA Approved Foundayo For
The U.S. Food & Drug Administration approved Foundayo on Apr. 1, 2026, for weight loss “in combination with a reduced-calorie diet and increased physical activity.” Specifically, eligible adults must have
- A BMI at or above 30, classifying them as obese, or
- A BMI of 27 plus at least one weight-related health condition
Foundayo Studies & Trial Data
The FDA mentioned two clinical trials in its announcement.
The first trial, published on September 16, 2025, in the New England Journal of Medicine, tracked adults with obesity for 72 weeks. Foundayo produced “significantly greater reductions” in weight than placebo and displayed a side effect profile consistent with drugs in its class.
The second trial came out Dec. 20, 2025, with similar findings. Among participants with obesity and type-II diabetes, orforglipron “significantly improved all specified weight and cardiometabolic measures.” Side effects were consistent with other trial data.
Clinical trials are thorough and rigorous, but results do not always align with all patient experiences. Trial data for Foundayo is solid, but you’ll need to have an informed conversation with your healthcare provider before starting or switching to another medication.
Check Foundayo Eligibility
Start with the online assessment to see whether Foundayo may be appropriate for you. A licensed provider will review your information and determine whether treatment may be a fit.
How Foundayo Is Taken
Foundayo is taken daily in tablet form. According to the official label, patients can take Foundayo at any time, with or without food—just be sure not to crush, break, or chew the pill.
Like other similar medications, Foundayo is formulated for titration. Meaning, you start with a conservative dose and gradually ramp up to what’s called a therapeutic dose, or the precise amount of medication for your needs as determined by your doctor.
Here’s the dosing schedule:
- Days 0-30: 0.8mg
- Days 31-60: 2.5mg
- Days 61+: 5.5mg
After reaching the 5.5mg benchmark two months in, your doctor may opt to continue titrating upward every month. Foundayo is available at 9mg, 14.5mg, and 17.5mg.
How Oral GLP-1 Medications Work
GLP stands for “glucagon-like peptide.” It’s a hormone your body produces to help your brain regulate eating habits. It also affects how fast you digest food and manages blood sugar.
GLP-1s are considered hormonal receptor “agonists” because they bind to the same crucial receptors as the natural version. Some GLP-1 medications are synthetic versions of this hormone. Foundayo, by contrast, is not a synthetic version of the peptide. It’s a small molecule that binds to GLP-1 receptors.
People with metabolic issues may also have imbalances in GLP-1 signaling, which is one reason external GLP-1 stimulation can be useful as part of treatment.
The key difference? GLP-1 drugs are much more durable and retain their positive effects longer than the version your body produces naturally.
Foundayo Common Side Effects
Foundayo presents a side effect profile largely consistent with other drugs in its class. Hallmark GLP-1 side effects include:
- Nausea
- Constipation
- Diarrhea
- Vomiting
- Indigestion
- Abdominal pain or cramps
- Bloating
- Gas
Among others. The Foundayo titration schedule is meant to smooth out the first weeks, when GLP-1 side effects are at their most prevalent. As with any prescription medication, you should contact your healthcare provider if your side effects persist longer than expected or worsen in intensity.
Important Warnings and Precautions
No drug is risk-free. The FDA’s guidance contains important information about Foundayo’s safety and risk factors for more serious conditions. Before starting treatment, you need to know the facts.
Thyroid Tumors
GLP-1s may carry a risk of developing thyroid tumors. This warning is based on rodent data and has not been replicated in human trials. That said, patients with personal or family histories of cancers like medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type-II should steer clear.
Pancreatitis & Gallbladder Symptoms
Some patients may experience pancreatitis or gallbladder issues while on GLP-1s. Trial data is conflicting, but you should keep a close eye on red flag symptoms regardless. Things to watch out for include abdominal pain absent other gastrointestinal symptoms like vomiting.
Pain in the upper right side of the stomach may signal a deeper issue, particularly if it radiates toward your spine.
Kidney Issues & Dehydration
There have been reports of acute kidney injury in some patients treated with Foundayo. The FDA remarks that most kidney-related issues occurred in patients suffering from dehydration. For anyone on a GLP-1, volume depletion, or the loss of both adequate water and salt content, is a real risk.
Medication Considerations
Foundayo delays gastric emptying. One downstream consequence of this is potentially affecting how your body processes and absorbs other medications. Your doctor should take this into consideration before starting you on a GLP-1.
Women taking oral contraceptives should also be wary. Foundayo’s prescribing information advises those using certain contraceptives to switch to a non-oral version.
You should not take Foundayo alongside another GLP-1.
What To Ask Your Doctor About Foundayo
Clarity is the antidote to anxiety. If you’re concerned about potentially starting Foundayo, take these questions to your appointment:
- Am I an appropriate candidate for Foundayo based on my medical history?
- How should I handle side effects like nausea, vomiting, or dehydration?
- Do any of my oral medications need to change if I start Foundayo?
- Can I keep using an oral hormonal contraceptive if I’m on Foundayo?
- What should I watch out for in terms of warning signs?
Bottom Line
Foundayo is a notable step forward for the GLP-1 class. As a small-molecule drug, it can be taken orally at any time without the food and water restrictions that come with other oral options.
Clinical trial data backs its ability to produce substantial weight loss, with a side effect profile consistent with other drugs in its class.
That said, it works best alongside real lifestyle changes, and your health history plays a role in whether it's the right fit.
If you're weighing your options, the questions above are a good place to start that conversation with your provider.
Frequently Asked Questions
Check Foundayo Eligibility
Start with the online assessment to see whether Foundayo may be appropriate for you. A licensed provider will review your information and determine whether treatment is a good fit.
By Jake Dickson, NASM-CPT, USAW-L2
Contributing Author
Jake holds a B.S. in Exercise Science from UNC Wilmington and began his career as a personal trainer and weightlifting coach. In recent years, he’s moved behind the page as a writer and editor, contributing hundreds of articles and being featured as a subject matter expert. Today, Jake’s goal remains the same: to empower people to change their lives by bringing heady scientific topics down to ground level.
